Clinical Trial Detail

NCT ID NCT03081780
Title Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications

acute myeloid leukemia

Therapies

FATE-NK100

Age Groups: adult senior

No variant requirements are available.